Medicines, 2014
Shortlist up to four to read them side by side.
1,562 medicine recalls FDA’s Enforcement Report published in 2014, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 6, 2026.
1,562of 1,562 medicine recallsshown with your filters
The list
- Medicine recall VITAMIN B COMPLEX PROLONGED RELEASE Tablet, 50 mg, Over The Counter Labeling: Label Mixup; VITAMIN B COMPLEX PROLONGED RELEASE, Tablet, 50 mg may be potentially mislabeled as COENZYME Q-10, Capsule, 100 mg, NDC 37205055065,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall OMEGA-3 FATTY ACID Capsule, 1000 mg, Over The Counter Labeling: Label Mixup; OMEGA-3 FATTY ACID Capsule, 1000 mg may be potentially mislabeled as PYRIDOXINE HCL, Tablet, 50 mg, NDC 00904052060, Pedigree:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall FEXOFENADINE HCL, Tablet 180 mg Labeling: Label Mixup; FEXOFENADINE HCL Tablet, 180 mg may be potentially mislabeled as MULTIVITAMIN/MULTIMINERAL, Tablet, NDC 00536406001, Pedigree:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall LEVOTHYROXINE/ LIOTHYRONINE Tablet, 19 mcg/4.5 mcg Labeling: Label Mixup; LEVOTHYROXINE/ LIOTHYRONINE Tablet, 19 mcg/4.5 mcg may be potentially mislabeled as MAGNESIUM GLUCONATE DIHYDRATE, Tablet, 500 mg (27 mg… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall LIOTHYRONINE SODIUM, Tablet, 5 mcg Labeling: Label Mixup; LIOTHYRONINE SODIUM Tablet, 5 mcg may be potentially mislabeled as HYDROCHLOROTHIAZIDE, Tablet, 12.5 mg, NDC 16729018201, Pedigree:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall LIOTHYRONINE SODIUM, Tablet 25 mcg Labeling: Label Mixup; LIOTHYRONINE SODIUM Tablet, 25 mcg may be potentially mislabeled as guanFACINE HCl, Tablet, 1 mg, NDC 00378116001, Pedigree: AD46414_22,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall PANCRELIPASE DR Capsule Labeling: Label Mixup; PANCRELIPASE DR Capsule may be potentially mislabeled as MELATONIN, Tablet, 1 mg, NDC 35046000391, Pedigree: W003317, EXP: 6/18/2014;… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall HYOSCYAMINE SULFATE ER, Tablet, 0.375 mg Labeling: Label Mixup; HYOSCYAMINE SULFATE ER Tablet, 0.375 mg may be potentially mislabeled as SERTRALINE HCL, Tablet, 50 mg, NDC 16714061204, Pedigree:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall LACTOBACILLUS ACIDOPHILUS Capsule, 500 Million CFU, Over The Counter Labeling: Label Mixup; LACTOBACILLUS ACIDOPHILUS, Capsule, 500 Million CFU may be potentially mislabeled as MELATONIN, Tablet, 3 mg, NDC 08770140813, Pedigree:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall VITAMIN B COMPLEX, Tablet Over The Counter Labeling: Label Mixup; VITAMIN B COMPLEX Tablet may be potentially mislabeled as OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,100 mg, NDC 11523726503,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall LACTOBACILLUS ACIDOPHILUS Capsule, 500 Million CFU, Over The Counter Labeling: Label Mixup; LACTOBACILLUS ACIDOPHILUS, Capsule, 500 Million CFU may be potentially mislabeled as DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall METHYLERGONOVINE MALEATE Tablet, 0.2 mg Labeling: Label Mixup; METHYLERGONOVINE MALEATE Tablet, 0.2 mg may be potentially mislabeled as ISOSORBIDE MONONITRATE, Tablet, 20 mg, NDC 62175010701,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall MISOPROSTOL Tablet, 100 mcg Labeling: Label Mixup; MISOPROSTOL Tablet, 100 mcg may be potentially mislabeled as QUINAPRIL HCL, Tablet, 10 mg, NDC 59762502001, Pedigree: AD42611_4, EXP:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall NIFEDIPINE Capsule, 10 mg Labeling: Label Mixup; NIFEDIPINE Capsule, 10 mg may be potentially mislabeled as MULTIVITAMIN/MULTIMINERAL W/FLUORIDE, Chew Tablet, 1 mg (F), NDC 64376081501,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall ORPHENADRINE CITRATE ER Tablet, 100 mg Labeling: Label Mixup; ORPHENADRINE CITRATE ER Tablet, 100 mg may be potentially mislabeled as OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall ISOMETHEPTENE MUCATE/ DICHLORALPHENAZONE/APAP Capsule, 65 mg/100 mg/325 mg Labeling: Label Mixup; ISOMETHEPTENE MUCATE/ DICHLORALPHENAZONE/APAP Capsule, 65 mg/100 mg/325 mg may be potentially mislabeled as ALBUTEROL SULFATE ER,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall FEXOFENADINE HCl Tablet, 60 mg Labeling: Label Mixup; FEXOFENADINE HCL Tablet, 60 mg may be potentially mislabeled as PYRIDOXINE HCL, Tablet, 50 mg, NDC 51645090901, Pedigree: W003019, EXP:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall guaiFENesin ER Tablet, 600 mg Labeling: Label Mixup; guaiFENesin ER, Tablet, 600 mg may be potentially mislabeled as FENOFIBRATE, Tablet, 54 mg, NDC 00378710077, Pedigree: AD21790_52, EXP:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall LORATADINE Tablet, 10 mg Labeling: Label Mixup; LORATADINE Tablet, 10 mg may be potentially mislabeled as GLYCOPYRROLATE, Tablet, 2 mg, NDC 00603318121, Pedigree: W002650, EXP:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall DESIPRAMINE HCL Tablet, 50 mg Labeling: Label Mixup; DESIPRAMINE HCL Tablet, 50 mg may be potentially mislabeled as clomiPRAMINE HCl, Capsule, 50 mg, NDC 51672401205, Pedigree: AD30140_4,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall ACETAMINOPHEN/ ASPIRIN/ CAFFEINE, Tablet, 250 mg/250 mg/65 mg, Over The Counter Labeling: Label Mixup; ACETAMINOPHEN/ ASPIRIN/ CAFFEINE, Tablet, 250 mg/250 mg/65 mg may be potentially mislabeled as MULTIVITAMIN/MULTIMINERAL, Chew Tablet,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall buPROPion HCl ER Tablet, 200 mg Labeling: Label Mixup; buPROPion HCl ER Tablet, 200 mg may be potentially mislabeled as AMANTADINE HCL, Capsule, 100 mg, NDC 00781204801, Pedigree: W002726,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall GALANTAMINE HBR ER Capsule, 24 mg Labeling: Label Mixup; GALANTAMINE HBR ER, Capsule, 24 mg may be potentially mislabeled as ESCITALOPRAM, Tablet, 5 mg, NDC 00093585001, Pedigree: W003733, EXP:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall QUETIAPINE FUMARATE Tablet, 12.5 mg Labeling: Label Mixup; QUETIAPINE FUMARATE Tablet, 12.5 mg (1/2 of 25 mg) may be potentially mislabeled as SIMVASTATIN, Tablet, 40 mg, NDC 00093715598,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall MELATONIN Tablet, 1 mg, Over The Counter Labeling: Label Mixup; MELATONIN, Tablet, 1 mg may be potentially mislabeled as hydrOXYzine PAMOATE, Capsule, 100 mg, NDC 00555032402, Pedigree: AD46265_28,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALS Capsule, 100 mg Labeling: Label Mixup; NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALS, Capsule, 100 mg may be potentially mislabeled as MINOCYCLINE HCL, Capsule, 50 mg, NDC… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall NITROFURANTOIN MACROCRYSTALS Capsule, 50 mg Labeling: Label Mixup; NITROFURANTOIN MACROCRYSTALS Capsule, 50 mg may be potentially mislabeled as PHYTONADIONE, Tablet, 5 mg, NDC 25010040515, Pedigree:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall LACTOBACILLUS GG Capsule, Over The Counter Labeling: Label Mixup; LACTOBACILLUS GG Capsule may be potentially mislabeled as VITAMIN B COMPLEX W/C, Capsule, NDC 54629008001, Pedigree: AD39560_4, EXP:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall LACTOBACILLUS GG Capsule, 10 Billion Cells, Over The Counter Labeling: Label Mixup; LACTOBACILLUS GG Capsule, 10 Billion Cells may be potentially mislabeled as guaiFENesin ER, Tablet, 600 mg, NDC 63824000815, Pedigree:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall LACTOBACILLUS GG Capsule, 15 Billion Cells, Over The Counter Labeling: Label Mixup; LACTOBACILLUS GG Capsule, 15 Billion Cells may be potentially mislabeled as ASPIRIN EC, Tablet, 325 mg, NDC 00904201360, Pedigree:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall ASPIRIN Tablet, 325 mg, Over The Counter Labeling: Label Mixup; ASPIRIN Tablet, 325 mg may be potentially mislabeled as CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: W002642, EXP:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall D-ALPHA TOCOPHERYL ACETATE Capsule, 400 units, Over The Counter Labeling: Label Mixup; D-ALPHA TOCOPHERYL ACETATE Capsule, 400 units may be potentially mislabeled as CYANOCOBALAMIN, Tablet, 500 mcg, NDC 00536355101,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall NICOTINE POLACRILEX Lozenge, 2 mg Labeling: Label Mixup; NICOTINE POLACRILEX Lozenge, 2 mg may be potentially mislabeled as VITAMIN B COMPLEX WITH C/FOLIC ACID, Tablet, NDC 60258016001,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall ASPIRIN EC DR Tablet, 81 mg, Over The Counter Labeling: Label Mixup; ASPIRIN EC DR Tablet, 81 mg may be potentially mislabeled as MELATONIN, Tablet, 3 mg, NDC 51991001406, Pedigree: AD28322_7, EXP:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall GLYCOPYRROLATE Tablet, 2 mg Labeling: Label Mixup; GLYCOPYRROLATE Tablet, 2 mg may be potentially mislabeled as LACTOBACILLUS, Tablet, NDC 64980012950, Pedigree: W003624, EXP: 1/31/2014. Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall DOXEPIN HCL Capsule, 150 mg Labeling: Label Mixup; DOXEPIN HCL Capsule, 150 mg may be potentially mislabeled as VALSARTAN, Tablet, 160 mg, NDC 00078035934, Pedigree: AD46312_7, EXP:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall DOXYCYCLINE MONOHYDRATE Capsule, 100 mg Labeling: Label Mixup; DOXYCYCLINE MONOHYDRATE Capsule, 100 mg may be potentially mislabeled as diphenhydrAMINE HCl, Tablet, 25 mg, NDC 00904555159, Pedigree:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall DILTIAZEM HCL ER Capsule, 240 mg Labeling: Label Mixup; DILTIAZEM HCL ER Capsule, 240 mg may be potentially mislabeled as NICOTINE POLACRILEX, Lozenge, 2 mg, NDC 37205098769, Pedigree:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall HYDRALAZINE HCL Tablet, 25 mg Labeling: Label Mixup; HYDRALAZINE HCL Tablet, 25 mg may be potentially mislabeled as DOCUSATE CALCIUM, Capsule, 240 mg, NDC 00536375501, Pedigree: AD49582_16,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall hydrALAZINE HCl Tablet, 50 mg Labeling: Label Mixup; hydrALAZINE HCl Tablet, 50 mg may be potentially mislabeled as CapsuleTOPRIL, Tablet, 12.5 mg, NDC 00143117101, Pedigree: AD52778_16,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall traZODone HCl Tablet, 50 mg Labeling: Label Mixup; traZODone HCl Tablet, 50 mg may be potentially mislabeled as DEXAMETHASONE, Tablet, 1 mg, NDC 00054418125, Pedigree: AD37088_1, EXP:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall traZODone HCl Tablet, 50 mg Labeling: Label Mixup; traZODone HCl Tablet, 50 mg may be potentially mislabeled as AMANTADINE HCL, Tablet, 100 mg, NDC 00832011100, Pedigree: AD54475_1, EXP:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall traZODone HCl Tablet, 150 mg Labeling: Label Mixup; traZODone HCl Tablet, 150 mg may be potentially mislabeled as NICOTINE POLACRILEX, Lozenge, 2 mg, NDC 00135051001, Pedigree: AD21858_1,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall TORSEMIDE Tablet, 10 mg Labeling: Label Mixup; TORSEMIDE, Tablet, 10 mg may be potentially mislabeled as PYRIDOXINE HCL, Tablet, 50 mg, NDC 00536440801, Pedigree: AD30197_22, EXP:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall RIVAROXABAN Tablet, 20 mg Labeling: Label Mixup; RIVAROXABAN Tablet, 20 mg may be potentially mislabeled as VENLAFAXINE HCL, Tablet, 100 mg, NDC 00093738301, Pedigree: W002619, EXP:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall TACROLIMUS Capsule, 1 mg Labeling: Label Mixup; TACROLIMUS, Capsule, 1 mg may be potentially mislabeled as LEVOTHYROXINE SODIUM, Tablet, 125 mcg, NDC 00074706890, Pedigree: AD70633_4,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall SOLIFENACIN SUCCINATE Tablet, 5 mg Labeling: Label Mixup; SOLIFENACIN SUCCINATE Tablet, 5 mg may be potentially mislabeled as BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg, NDC 00574010601, Pedigree:… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
- Medicine recall PYRIDOXINE HCL Tablet, 50 mg, Over The Counter Labeling: Label Mixup; PYRIDOXINE HCL Tablet, 50 mg may be potentially mislabeled as CALCIUM CITRATE, Tablet, 950 mg (200 mg Elem Ca), NDC 00904506260,… Class IIFDA’s classJan 22, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedJan 22, 2014ClassClass IIStatusTerminatedWhereArizona, California, Oregon and Washington
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.